NCT03018444View on ClinicalTrials.gov

The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase Inhibitors
Interventions
DRUG

Atorvastatin

Atorvastatin tablet

OTHER

Placebo

Placebo tablet

Trial Locations (1)

2900

University Hospital, Gentofte, Copenhagen, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03018444 - The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion | Biotech Hunter | Biotech Hunter